Humanin was cloned and identified from an apparently normal region of brain with Alzheimer's disease in 2001 and was considered as Alzheimer's disease-selective neuroprotective peptide. Here, MT-RNR2 is linked to early-onset autosomal dominant Alzheimer disease.